There is discussion of expanding newborn screening (NBS) through the use of genomic sequence data; yet. challenges remain in the interpretation of DNA variants. Population-level DNA variant databases are available. and it is possible to estimate the number of newborns who would be flagged as having a risk for a genetic disease (including rare variants of unknown significance. https://herbsdailyes.shop/product-category/allergy-relief/